Advertisement
Screener

PULMONX CORPORATION (LUNG) Deferred Costs, Noncurrent

2.8 / 5 stars · 68/120 Roast Me

PULMONX CORPORATION Deferred Costs, Noncurrent

PULMONX CORPORATION (LUNG) had Deferred Costs, Noncurrent of $1.80 million as of 2021-09-30, per its 10-Q filed 2021-11-09.

Discontinued › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:DeferredCosts · last filed 2022-03-01

  • 2021-09-30: Deferred Costs, Noncurrent $1.80M.
  • 2021-06-30: Deferred Costs, Noncurrent $1.80M.
  • 2021-03-31: Deferred Costs, Noncurrent $1.80M.
  • 2020-12-31: Deferred Costs, Noncurrent $0.00.
Period endDeferred Costs, NoncurrentDeferred Costs, Noncurrent as first filed
2021-09-30$1.80M
10-Q · filed 2021-11-09
2021-06-30$1.80M
10-Q · filed 2021-08-10
2021-03-31$1.80M
10-Q · filed 2021-05-12
2020-12-31$0.00
10-K · filed 2021-03-15
2020-09-30$1.68M
10-Q · filed 2020-11-13
2019-12-31$1.60M
10-K · filed 2022-03-01
$1.56M
10-Q · filed 2020-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
SkinHealth Systems Inc. (SKIN)United States$0.086B-3.17
LENSAR, Inc. (LNSR)United States$0.087B2.02
RenovoRx, Inc. (RNXT)United States$0.076B-3.62
Microbot Medical Inc. (MBOT)$0.089B-7.97
FRACTYL HEALTH, INC. (GUTS)United States$0.075B-1.18
CVRx, Inc. (CVRX)United States$0.067B-2.62
DarioHealth Corp. (DRIO)$0.066B-1.39
TELA Bio, Inc. (TELA)United States$0.057B-0.82
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Spectral AI, Inc. (MDAI)United States$0.052B